A. Guerrero

643 total citations
16 papers, 279 citations indexed

About

A. Guerrero is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Guerrero has authored 16 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Guerrero's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (13 papers) and Advanced Radiotherapy Techniques (8 papers). A. Guerrero is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (13 papers) and Advanced Radiotherapy Techniques (8 papers). A. Guerrero collaborates with scholars based in Spain. A. Guerrero's co-authors include A. Álvarez, Felipe A. Calvo, Francesc Casas, A. Zapatero, M. L. Vázquez de la Torre, Xavier Maldonado, C. Martín de Vidales, A. Boladeras, María Ángeles Cabeza Rodríguez and Víctor Macías and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

A. Guerrero

16 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Guerrero Spain 5 263 91 31 31 28 16 279
M. L. Vázquez de la Torre Spain 6 266 1.0× 92 1.0× 34 1.1× 31 1.0× 29 1.0× 12 283
Carmen González San Segundo Spain 6 265 1.0× 87 1.0× 34 1.1× 34 1.1× 34 1.2× 26 288
María Ángeles Cabeza Rodríguez Spain 6 290 1.1× 98 1.1× 34 1.1× 37 1.2× 39 1.4× 11 318
Robert Archambault Canada 9 276 1.0× 87 1.0× 31 1.0× 27 0.9× 12 0.4× 31 299
Alexander G. Balogh Canada 7 189 0.7× 36 0.4× 25 0.8× 17 0.5× 25 0.9× 10 223
Kenneth L. Zeitzer United States 10 255 1.0× 49 0.5× 30 1.0× 31 1.0× 32 1.1× 22 297
Chris Brawley United Kingdom 5 265 1.0× 52 0.6× 36 1.2× 31 1.0× 71 2.5× 11 301
Rédouane Bettahar Canada 7 201 0.8× 90 1.0× 43 1.4× 20 0.6× 23 0.8× 16 275
Steve Angyalfi Canada 6 169 0.6× 68 0.7× 22 0.7× 18 0.6× 20 0.7× 14 185
Archi Agarwal India 6 198 0.8× 98 1.1× 50 1.6× 26 0.8× 41 1.5× 15 260

Countries citing papers authored by A. Guerrero

Since Specialization
Citations

This map shows the geographic impact of A. Guerrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Guerrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Guerrero more than expected).

Fields of papers citing papers by A. Guerrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Guerrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Guerrero. The network helps show where A. Guerrero may publish in the future.

Co-authorship network of co-authors of A. Guerrero

This figure shows the co-authorship network connecting the top 25 collaborators of A. Guerrero. A scholar is included among the top collaborators of A. Guerrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Guerrero. A. Guerrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2022). High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial. The Lancet Oncology. 23(5). 671–681. 23 indexed citations
2.
Zapatero, A., A. Álvarez, A. Guerrero, et al.. (2021). Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial. Radiotherapy and Oncology. 160. 115–119. 7 indexed citations
3.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2021). Ten-Year Results of a Phase III Randomised Trial of High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localised Prostate Cancer. SSRN Electronic Journal. 1 indexed citations
4.
5.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2016). Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 96(2). 341–348. 20 indexed citations
6.
Zapatero, A., A. Guerrero, A. Álvarez, et al.. (2016). Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial. International Journal of Radiation Oncology*Biology*Physics. 96(2). S139–S140. 1 indexed citations
7.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2015). High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial. The Lancet Oncology. 16(3). 320–327. 206 indexed citations
8.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2014). Long-term versus short-term androgen deprivation combined with high-dose radiotherapy for intermediate and high-risk prostate cancer: A randomized controlled trial (DART01/05).. Journal of Clinical Oncology. 32(15_suppl). 5038–5038. 1 indexed citations
9.
Zapatero, A., A. Guerrero, A. Álvarez, et al.. (2014). Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 90(1). S1–S1. 4 indexed citations
10.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2013). Late Side Effects in Men With Intermediate- and High-Risk Prostate Cancer Treated With High-Dose Radiation Therapy and Androgen Deprivation (DART 01/05): Secondary Endpoints From a Phase 3 Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 87(2). S105–S105. 2 indexed citations
11.
12.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2012). OC-0048 LONG VS. SHORT-TERM ANDROGEN DEPRIVATION PLUS 78 GY 3DCRT FOR PROSTATE CANCER: PRELIMINARY RESULTS DART01/05 TRIAL. Radiotherapy and Oncology. 103. S18–S19. 1 indexed citations
13.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2011). Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.. Journal of Clinical Oncology. 29(15_suppl). 4580–4580. 4 indexed citations
14.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2011). Long-term vs. Short-term Androgen Deprivation Combined with High-dose Radiotherapy for Intermediate and High-risk Prostate Cancer: Preliminary Results of a GICOR Phase III Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 81(2). S40–S40. 1 indexed citations
15.
Zapatero, A., A. Guerrero, Xavier Maldonado, et al.. (2010). Long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: A Spanish multicenter phase III trial.. Journal of Clinical Oncology. 28(15_suppl). e15036–e15036. 4 indexed citations
16.
Stewart, Josephine, Semiglazov Vf, Henry Gómez, et al.. (2008). 5,10 methylenetetrahydrofolic acid with fluorouracil as treatment for advanced breast cancer in patients who failed prior treatment with anthracyclines and taxanes: A phase II study. Journal of Clinical Oncology. 26(15_suppl). 1136–1136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. L. Vázquez de la Torre Breakdown of academic impact, for papers by Carmen González San Segundo Breakdown of academic impact, for papers by María Ángeles Cabeza Rodríguez Breakdown of academic impact, for papers by Robert Archambault Breakdown of academic impact, for papers by Alexander G. Balogh Breakdown of academic impact, for papers by Kenneth L. Zeitzer Breakdown of academic impact, for papers by Chris Brawley Breakdown of academic impact, for papers by Rédouane Bettahar Breakdown of academic impact, for papers by Steve Angyalfi Breakdown of academic impact, for papers by Archi Agarwal
Rankless by CCL
2026